摘要: Pulmonary manifestations of systemic sclerosis (SSc, scleroderma) are manifold (Table 1) and often have a profound influence on the course disease. A discussion all pulmonary complications SSc is beyond scope this article but presented in recent review. 10 The two major conditions occurring among patients, hypertension interstitial fibrosis 2), will be discussed detail. Isolated occurs primarily patients with limited cutaneous (calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, telangiectasia [CREST] variant) absence significant fibrosis, whereas either or diffuse SSc.
sci-hub.se 参考文章(92)
Ludwicka A, Trojanowska M, Strange C, Smith Ea, Leroy Ec, Korn Jh, Silver Rm, Smith T, Baumann M, Growth and characterization of fibroblasts obtained from bronchoalveolar lavage of patients with scleroderma. The Journal of Rheumatology. ,vol. 19, pp. 1716- 1723 ,(1992)
M. B. Kinsella, M. H. Baumann, C. Strange, R. M. Silver, L. S. Staudt, J. H. Warrick, Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease. The Journal of Rheumatology. ,vol. 20, pp. 838- 844 ,(1993)
Grosbois Jm, Tonnel Ab, Devulder B, Voisin C, Wallaert B, Hatron Py, Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage. Relationship between alveolitis and subsequent changes in lung function. The American review of respiratory disease. ,vol. 133, pp. 574- 580 ,(1986) , 10.1164/ARRD.1986.133.4.574
A. P. Sappino, G. Gabbiani, J. H. Saurat, I. Masouyé, Smooth muscle differentiation in scleroderma fibroblastic cells American Journal of Pathology. ,vol. 137, pp. 585- 591 ,(1990)
V J Ferrans, R G Crystal, O Kawanami, G W Hunninghake, J E Gadek, Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. American Journal of Pathology. ,vol. 97, pp. 149- 206 ,(1979)
William A. D'Angelo, James F. Fries, Alfonse T. Masi., Lawrence E. Shulman, Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls The American Journal of Medicine. ,vol. 46, pp. 428- 440 ,(1969) , 10.1016/0002-9343(69)90044-8
M. B. Urowitz, P. N. Madras, M. Baron, G. Skrinskas, Prostaglandin E1 therapy for digital ulcers in scleroderma Canadian Medical Association Journal. ,vol. 126, pp. 42- 45 ,(1982)
S I Schabel, R M Silver, J H Warrick, M Bhalla, High resolution computed tomography in early scleroderma lung disease. The Journal of Rheumatology. ,vol. 18, pp. 1520- 1528 ,(1991)
K. C. Flanders, S. H. Phan, Kai Zhang, Cellular localization of transforming growth factor-beta expression in bleomycin-induced pulmonary fibrosis. American Journal of Pathology. ,vol. 147, pp. 352- 361 ,(1995)
Gerhard König, Christoph Luderschmidt, Claus Hammer, Bernhard C. Adelmann-Grill, Otto Braun-Falco, Günter Fruhmann, Lung Involvement in Scleroderma Chest. ,vol. 85, pp. 318- 324 ,(1984) , 10.1378/CHEST.85.3.318